A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data ...
In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...
Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...
Health and Me on MSN
New AI-powered blood test to detect pancreatic cancer early with 94% accuracy
Pancreatic cancer is the 12th most common cancer worldwide. In 2022, there were 510,992 new cases of pancreatic cancer, with China, the US, and Japan reporting the highest number of cases globally.
Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results